drug · small molecule
remlifanserin
Phase 3updated 6mo agoby $ACAD ACADIA PHARMACEUTICALS INC🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug.
indications
indications
Alzheimer's Disease
all catalysts(0)
nothing on the calendar yet
News(4)
- Alzheimer’s field looks beyond amyloid as biopharma converges at CTAD 2026This week, biopharma companies including Biogen, Bristol Myers Squibb and Roche are in Boston with new data on their efforts to tackle Alzheimer’s disease.biospace · 1d ago
- Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s dataNovo’s latest alliance involves injectables given every one to three months. Elsewhere, Nektar won a legal spat with Eli Lilly and the FDA issued two approvals.biopharma_dive · 1mo ago
- Acadia slides on Phase 2 miss in Alzheimer’s psychosis but keeps moving asset forwardWhile Acadia Pharmaceuticals’ candidate has missed the main goal of a Phase 2 trial, the company is still moving forward with the anti-psychosis candidate in Alzheimer’s disease as well as Lewy bod…biospace · 1mo ago
- Acadia misses mark in Alzheimer’s but concludes phase 3 ‘absolutely worth’ pursuingAcadia Pharmaceuticals’ phase 2 Alzheimer’s disease trial has missed its primary endpoint, but the company and analysts alike saw enough encouraging signals to support the continuation of a phase 3…fiercebiotech · 1mo ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that